{"entity":{"type":"insider","cik":"0001631667","url":"/insider/0001631667","json_url":"/insider/0001631667.json","name":"Powell Lynne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":12,"first":"2018-10-23","last":"2019-01-29","span_basis":"filed_date"},"name_variants":[{"name":"Powell Lynne","source":"filing","n_filings":12,"first_seen":"2018-10-23","last_seen":"2019-01-29"}],"transactions":[{"id":8442275,"accession":"0001127602-19-002873","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-19-002873","line_url":"/filing/0001127602-19-002873","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.89,"price_display":"9.89","price_state":"stated","total_value":59340.0,"total_display":"59,340.00","total_whole":"59,340","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-29","scope":"insider","n_lines":2},{"id":8442256,"accession":"0001127602-19-002873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-002873","line_url":"/filing/0001127602-19-002873#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":57600.0,"total_display":"57,600.00","total_whole":"57,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-25","filed_date":"2019-01-29","scope":"insider"},{"id":8123813,"accession":"0001127602-19-002527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-002527","line_url":"/filing/0001127602-19-002527#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":9.4,"price_display":"9.40","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-18","filed_date":"2019-01-23","scope":"insider"},{"id":7814228,"accession":"0001127602-19-002367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-002367","line_url":"/filing/0001127602-19-002367#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3046.0,"shares_display":"3,046","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":28236.42,"total_display":"28,236.42","total_whole":"28,236","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-18","scope":"insider"},{"id":8511442,"accession":"0001127602-19-002141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-002141","line_url":"/filing/0001127602-19-002141#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":954.0,"shares_display":"954","price_per_share":9.2,"price_display":"9.20","price_state":"stated","total_value":8776.8,"total_display":"8,776.80","total_whole":"8,777","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-14","filed_date":"2019-01-16","scope":"insider"},{"id":6527566,"accession":"0001127602-18-036067","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-18-036067","line_url":"/filing/0001127602-18-036067","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.06,"price_display":"9.06","price_state":"stated","total_value":36240.0,"total_display":"36,240.00","total_whole":"36,240","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider","n_lines":2},{"id":6050944,"accession":"0001127602-18-034303","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-18-034303","line_url":"/filing/0001127602-18-034303","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14455.0,"shares_display":"14,455","price_per_share":9.051508128675199,"price_display":"9.05","price_state":"stated","total_value":130839.55,"total_display":"130,839.55","total_whole":"130,840","shares_owned_after":2455.0,"shares_owned_after_display":"2,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2018-11-26","scope":"insider","n_lines":2},{"id":6611901,"accession":"0001127602-18-034196","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-18-034196","line_url":"/filing/0001127602-18-034196","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15277.0,"shares_display":"15,277","price_per_share":8.556230935393074,"price_display":"8.56","price_state":"stated","total_value":130713.54,"total_display":"130,713.54","total_whole":"130,714","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2018-11-21","scope":"insider","n_lines":2},{"id":6611892,"accession":"0001127602-18-034196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-034196","line_url":"/filing/0001127602-18-034196#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193.0,"shares_display":"193","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":1601.9,"total_display":"1,601.90","total_whole":"1,602","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-21","scope":"insider"},{"id":6050761,"accession":"0001127602-18-032640","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-18-032640","line_url":"/filing/0001127602-18-032640#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5280.0,"shares_display":"5,280","price_per_share":8.15,"price_display":"8.15","price_state":"stated","total_value":43032.0,"total_display":"43,032.00","total_whole":"43,032","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-09","scope":"insider"},{"id":6050755,"accession":"0001127602-18-032640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-032640","line_url":"/filing/0001127602-18-032640#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","total_whole":"2,400","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-09","scope":"insider"},{"id":6050739,"accession":"0001127602-18-032413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-032413","line_url":"/filing/0001127602-18-032413#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-07","scope":"insider"},{"id":6388209,"accession":"0001127602-18-032278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-032278","line_url":"/filing/0001127602-18-032278#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":6909927,"accession":"0001127602-18-032034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-032034","line_url":"/filing/0001127602-18-032034#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1544.0,"shares_display":"1,544","price_per_share":7.51,"price_display":"7.51","price_state":"stated","total_value":11595.44,"total_display":"11,595.44","total_whole":"11,595","shares_owned_after":8605.0,"shares_owned_after_display":"8,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":6188816,"accession":"0001127602-18-030769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-030769","line_url":"/filing/0001127602-18-030769#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001631667","owner_name":"Powell Lynne","owner_display_name":"Powell Lynne","owner_url":"/insider/0001631667","role":"Officer (Senior VP - CCO)","role_mark":"O","role_mark_label":"Officer (Senior VP - CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":10149.0,"shares_owned_after_display":"10,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-19","filed_date":"2018-10-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Officer (Senior VP - CCO)","n_filings":12,"first_seen":"2018-10-23","last_seen":"2019-01-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001631667","retrieved_at":"2026-08-22T18:32:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}